Advances in lymphatic metastasis of non-small cell lung cancer

被引:3
|
作者
Zhang, Xiaofei [1 ]
Ma, Li [1 ]
Xue, Man [1 ]
Sun, Yanning [1 ]
Wang, Zhaoxia [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 2, Canc Med Ctr, Nanjing 210011, Peoples R China
关键词
NSCLC; Lymphatic metastasis; Lymphatic endothelial cells; Vascular endothelial growth factor; Immune microenvironment; Biomarker; GROWTH-FACTOR-C; NODE METASTASIS; VEGF-C; TUMOR LYMPHANGIOGENESIS; MOLECULAR-MECHANISMS; MICROVESSEL DENSITY; PROGNOSTIC IMPACT; FACTOR RECEPTOR-2; DOWN-REGULATION; PLATELET COUNT;
D O I
10.1186/s12964-024-01574-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lung cancer is a deeply malignant tumor with high incidence and mortality. Despite the rapid development of diagnosis and treatment technology, abundant patients with lung cancer are still inevitably faced with recurrence and metastasis, contributing to death. Lymphatic metastasis is the first step of distant metastasis and an important prognostic indicator of non-small cell lung cancer. Tumor-induced lymphangiogenesis is involved in the construction of the tumor microenvironment, except promoting malignant proliferation and metastasis of tumor cells, it also plays a crucial role in individual response to treatment, especially immunotherapy. Thus, this article reviews the current research status of lymphatic metastasis in non-small cell lung cancer, in order to provide some insights for the basic research and clinical and translational application in this field.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] THE SITUATION AND ADVANCES OF THE VACCINES FOR NON-SMALL CELL LUNG CANCER
    Li, Y.
    RESPIROLOGY, 2011, 16 : 155 - 155
  • [32] ADVANCES IN THE BIOLOGY OF NON-SMALL CELL LUNG-CANCER
    GAZDAR, AF
    CHEST, 1986, 89 (04) : S277 - S283
  • [33] Recent advances in the treatment of non-small cell lung cancer
    Goss, GD
    Dahrouge, S
    Lochrin, CA
    ANTI-CANCER DRUGS, 1996, 7 (04) : 363 - 385
  • [34] New advances in immunotherapy for non-small cell lung cancer
    Qin, Haifeng
    Wang, Fang
    Liu, Hui
    Zeng, Zhen
    Wang, Shasha
    Pan, Xin
    Gao, Hongjun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2234 - 2245
  • [35] Advances in the Treatment of Non-Small Cell Lung Cancer: Immunotherapy
    Patel, Shetal A.
    Weiss, Jared
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 237 - +
  • [36] Advances in the Diagnosis and Treatment of Non-Small Cell Lung Cancer
    Pillai, Rathi N.
    Ramalingam, Suresh S.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (03) : 557 - 564
  • [37] Recent advances in the chemotherapy of non-small cell lung cancer
    Inoue, A
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (07) : 299 - 304
  • [38] Analysis of factors influencing skip lymphatic metastasis in pN2 non-small cell lung cancer
    Li, Gui-Long
    Zhu, Yong
    Zheng, Wei
    Guo, Chao-Hui
    Chen, Chun
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (04) : 340 - 345
  • [39] Analysis of factors influencing skip lymphatic metastasis in pN2 non-small cell lung cancer
    Gui-Long Li
    Yong Zhu
    Wei Zheng
    Chao-Hui Guo
    Chun Chen
    ChineseJournalofCancerResearch, 2012, 24 (04) : 340 - 345
  • [40] Pituitary Metastasis of Non-Small Cell Lung Cancer With High FDG Uptake on PET/CT Pituitary Metastasis of Non-Small Cell Lung Carcinoma
    Le Meur, Coline
    Campedel, Luca
    Kharroubi, Dris
    Amrane, Karim
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (07) : E506 - E508